These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22300406)

  • 41. Early-life Pb exposure as a potential risk factor for Alzheimer's disease: are there hazards for the Mexican population?
    Chin-Chan M; Cobos-Puc L; Alvarado-Cruz I; Bayar M; Ermolaeva M
    J Biol Inorg Chem; 2019 Dec; 24(8):1285-1303. PubMed ID: 31773268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.
    Basha MR; Wei W; Bakheet SA; Benitez N; Siddiqi HK; Ge YW; Lahiri DK; Zawia NH
    J Neurosci; 2005 Jan; 25(4):823-9. PubMed ID: 15673661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Basis of Familial and Sporadic Alzheimer's Disease.
    Dorszewska J; Prendecki M; Oczkowska A; Dezor M; Kozubski W
    Curr Alzheimer Res; 2016; 13(9):952-63. PubMed ID: 26971934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation.
    Basha MR; Murali M; Siddiqi HK; Ghosal K; Siddiqi OK; Lashuel HA; Ge YW; Lahiri DK; Zawia NH
    FASEB J; 2005 Dec; 19(14):2083-4. PubMed ID: 16230335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
    Lahiri DK; Sambamurti K; Bennett DA
    Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities.
    Cummings JL; Vinters HV; Cole GM; Khachaturian ZS
    Neurology; 1998 Jul; 51(1 Suppl 1):S2-17; discussion S65-7. PubMed ID: 9674758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pathological changes induced by amyloid-β in Alzheimer's disease].
    Takata K; Kitamura Y; Taniguchi T
    Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.
    Hunter S; Arendt T; Brayne C
    Mol Neurobiol; 2013 Dec; 48(3):556-70. PubMed ID: 23546742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects.
    Rocchi A; Orsucci D; Tognoni G; Ceravolo R; Siciliano G
    Curr Alzheimer Res; 2009 Jun; 6(3):224-37. PubMed ID: 19519304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic noise exposure and Alzheimer disease: Is there an etiological association?
    Cui B; Li K
    Med Hypotheses; 2013 Oct; 81(4):623-6. PubMed ID: 23899629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Alzheimer's disease: basic aspects].
    Iwatsubo T
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):207-11. PubMed ID: 10879068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.
    Conway KA; Baxter EW; Felsenstein KM; Reitz AB
    Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alzheimer's disease: a re-examination of the amyloid hypothesis.
    Neve RL; Robakis NK
    Trends Neurosci; 1998 Jan; 21(1):15-9. PubMed ID: 9464679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.